Vemurafenib treatment for patients with locally advanced, unresectable stage IIIC or metastatic melanoma and activating exon 15 BRAF mutations other than V600E
Hallmeyer, Sigrun, Gonzalez, Rene, Lawson, David H., Cranmer, Lee D., Linette, Gerald P., Puzanov, Igor, Taback, Bret, Cowey, C. Lance, Ribas, Antoni, Daniels, Gregory A., Moore, Timothy, Gibney, GeofVolume:
27
Language:
english
Journal:
Melanoma Research
DOI:
10.1097/CMR.0000000000000398
Date:
December, 2017
File:
PDF, 147 KB
english, 2017